文献速递皮肤感染

美国急诊科蜂窝织炎与丹毒的疾病负担、危险因素及感染性并发症

Burden, risk factors, and infectious complications of cellulitis and erysipelas in US adults and children in the emergency department setting.
PubMed 文献 · J Am Acad Dermatol · 2020-11-22

基于2006至2016年美国全国急诊科样本(含20%抽样,N=320,080,467)的横断面研究显示,蜂窝织炎/丹毒急诊就诊年均发病率成人2.42–3.55/百万、儿童1.14–2.09/百万,就诊量显著下降但费用翻倍或三倍增长,且与公共保险/无保险及低收入相关。

要点

  • 蜂窝织炎/丹毒急诊就诊量2006–2015年显著下降(P<.0001)
  • 成人急诊费用从720美元增至1680美元,儿童从939美元增至2823美元
  • 就诊多与公共保险/无保险及低收入四分位相关,周末和夏季更常见

核心结论

  • 美国蜂窝织炎/丹毒急诊就诊负担巨大且费用持续增加。
  • 许多急诊就诊为无并发症的蜂窝织炎/丹毒,部分源于医疗保健差异。

研究设计与样本

  • 横断面研究,使用2006至2016年美国全国急诊科样本,包含20%的美国急诊就诊抽样(N=320,080,467)。

主要发现

  • 蜂窝织炎/丹毒作为主要诊断的急诊就诊年均发病率成人为2.42–3.55/百万,儿童为1.14–2.09/百万。
  • 2006至2015年蜂窝织炎/丹毒急诊就诊显著下降(Rao-Scott卡方检验,P<.0001)。
  • 与无此主要诊断的急诊就诊相比,蜂窝织炎/丹毒就诊更多见于公共保险或无保险及较低家庭收入四分位人群,且更常发生在周末和夏季月份。
  • 2006至2016年,成人蜂窝织炎/丹毒急诊平均费用从720美元增至1680美元(翻倍以上),儿童从939美元增至2823美元(三倍)。
  • 蜂窝织炎/丹毒急诊就诊与多种危险因素及感染性并发症增加相关。

临床怎么用

  • 急诊医生应关注蜂窝织炎/丹毒就诊中的医疗保健差异因素。
  • 无并发症蜂窝织炎/丹毒在急诊就诊中占相当比例,需优化分诊与处置。

局限性

  • 缺乏蜂窝织炎和丹毒治疗或复发的数据。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Little is known about the use and burden of emergency department (ED) visits for cellulitis/erysipelas in the United States. OBJECTIVE: To determine the prevalence, risk factors, complications, and cost of emergency care for cellulitis/erysipelas in the United States. METHODS: Cross-sectional study of the 2006 to 2016 National Emergency Department Sample, including a 20% sample of US ED visits (N = 320,080,467). RESULTS: The mean annual incidence of ED visits with a primary diagnosis of cellulitis/erysipelas was 2.42 to 3.55 per million adult and 1.14 to 2.09 per million pediatric ED visits. ED visits for cellulitis/erysipelas decreased significantly from 2006 to 2015 (Rao-Scott chi-square, P < .0001). ED visits with versus without a primary diagnosis of cellulitis/erysipelas were associated with public or no insurance and lower household income quartiles, and were more likely to occur during weekends and summer months. The mean cost of ED visits for cellulitis/erysipelas more than doubled in adults (from $720 to $1680) and tripled in children (from $939 to $2,823) from 2006 to 2016. ED visits for cellulitis/erysipelas were associated with multiple risk factors and increased infectious complications. LIMITATIONS: No data on cellulitis and erysipelas treatment or recurrence. CONCLUSION: There is a substantial and increasing burden of ED visits for cellulitis/erysipelas in the United States. Many ED visits occurred for uncomplicated cellulitis/erysipelas, in part because of health care disparities.

来源:J Am Acad Dermatol,查看原文。版权归原作者所有。

引用

  1. Ren Z, Silverberg JI. Burden, risk factors, and infectious complications of cellulitis and erysipelas in US adults and children in the emergency department setting. J Am Acad Dermatol. 2020. PMID: 33238162. doi:10.1016/j.jaad.2020.11.021

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。